 - Myelosuppressive chemotherapy: must not have received within 3 weeks of enrollment onto this study 6 weeks if prior nitrosourea; hydroxyurea may be administered prior to study enrollment; in such cases at least 24 hours must have elapsed between the last dose of hydroxyurea and the first dose of obatoclax 